| 000 | 01903 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250517205408.0 | ||
| 264 | 0 | _c20190415 | |
| 008 | 201904s 0 0 eng d | ||
| 022 | _a1478-6362 | ||
| 024 | 7 |
_a10.1186/s13075-018-1545-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWeigold, Florian | |
| 245 | 0 | 0 |
_aAntibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis. _h[electronic resource] |
| 260 |
_bArthritis research & therapy _c03 2018 |
||
| 300 |
_a52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAutoantibodies _xblood |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung _xphysiology |
| 650 | 0 | 4 |
_aLung Diseases _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 |
_aReceptors, CXCR3 _xblood |
| 650 | 0 | 4 |
_aReceptors, CXCR4 _xblood |
| 650 | 0 | 4 |
_aRespiratory Function Tests _xtrends |
| 650 | 0 | 4 |
_aScleroderma, Systemic _xblood |
| 700 | 1 | _aGünther, Jeannine | |
| 700 | 1 | _aPfeiffenberger, Moritz | |
| 700 | 1 | _aCabral-Marques, Otavio | |
| 700 | 1 | _aSiegert, Elise | |
| 700 | 1 | _aDragun, Duska | |
| 700 | 1 | _aPhilippe, Aurélie | |
| 700 | 1 | _aRegensburger, Ann-Katrin | |
| 700 | 1 | _aRecke, Andreas | |
| 700 | 1 | _aYu, Xinhua | |
| 700 | 1 | _aPetersen, Frank | |
| 700 | 1 | _aCatar, Rusan | |
| 700 | 1 | _aBiesen, Robert | |
| 700 | 1 | _aHiepe, Falk | |
| 700 | 1 | _aBurmester, Gerd R | |
| 700 | 1 | _aHeidecke, Harald | |
| 700 | 1 | _aRiemekasten, Gabriela | |
| 773 | 0 |
_tArthritis research & therapy _gvol. 20 _gno. 1 _gp. 52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s13075-018-1545-8 _zAvailable from publisher's website |
| 999 |
_c28205848 _d28205848 |
||